BWS
IART icon

Buck Wealth Strategies’s Integra LifeSciences IART Stock Holding History

Buck Wealth Strategies’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-48,484
Closed -$1.72M – 92
2024
Q1 		$1.72M Buy
+48,484
New +$1.94M 0.59% 41

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Buck Wealth Strategies's IART Position: Q2 2024 in Review

Buck Wealth Strategies sold out of Integra LifeSciences (IART) in Q2 2024, closing a stake of 48,484 shares — an estimated $1.72M sold.

Buck Wealth Strategies first reported a position in IART in Q1 2024 and held it in 1 quarter. The position peaked at $1.72M in Q1 2024. 238 funds tracked by Wall St. Rank hold IART as of Q2 2024.

  • Buck Wealth Strategies reported no remaining Integra LifeSciences position as of Q2 2024 after selling out during the quarter.
  • Buck Wealth Strategies sold 48,484 Integra LifeSciences shares in Q2 2024, an estimated $1.72M.
  • Buck Wealth Strategies first reported a position in Integra LifeSciences in Q1 2024 and held it in 1 quarter.
  • Buck Wealth Strategies's Integra LifeSciences position peaked at $1.72M in Q1 2024.
  • 238 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2024.

Based on Buck Wealth Strategies's 13F filing for Q2 2024, filed 15 Aug 2024.